Flow Diversion for Ophthalmic Artery Aneurysms

References

1. 1.↵
   2. D'Urso PI,
   3. Lanzino G,
   4. Cloft HJ, et al

   . Flow diversion for intracranial aneurysms: a review. Stroke 2011;42:2363–68 doi:10.1161/STROKEAHA.111.620328 pmid:21737793

   Abstract/FREE Full Text
2. 2.↵
   2. Fang S,
   3. Lanzino G

   . Paraclinoid aneurysms: is there a new endovascular standard? Neurol Res 2014;36:314–22 doi:10.1179/1743132814Y.0000000326 pmid:24617932

   CrossRefPubMed
3. 3.↵
   2. Wakhloo AK,
   3. Tio FO,
   4. Lieber BB, et al

   . Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR Am J Neuroradiol 1995;16:1043–51 pmid:7639126

   Abstract
4. 4.↵
   2. Kallmes DF,
   3. Ding YH,
   4. Dai D, et al

   . A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007;38:2346–52 doi:10.1161/STROKEAHA.106.479576 pmid:17615366

   Abstract/FREE Full Text
5. 5.↵
   2. Trager AL,
   3. Sadasivan C,
   4. Seong J, et al

   . Correlation between angiographic and particle image velocimetry quantifications of flow diverters in an in vitro model of elastase-induced rabbit aneurysms. J Biomech Eng 2009;131:034506 doi:10.1115/1.3049528 pmid:19154077

   CrossRefPubMed
6. 6.↵
   2. Becske T,
   3. Kallmes DF,
   4. Saatci I, et al

   . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Lubicz B,
   3. Collignon L,
   4. Raphaeli G, et al

   . Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms. World Neurosurg 2011;76:114–19 doi:10.1016/j.wneu.2011.02.015 pmid:21839962

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Lylyk P,
   3. Miranda C,
   4. Ceratto R, et al

   . Curative endovascular reconstruction of cerebral aneurysms with the Pipeline embolization device: the Buenos Aires experience. Neurosurgery 2009;64:632–42; discussion 642–43 doi:10.1227/01.NEU.0000339109.98070.65 pmid:19349825

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Nelson PK,
   3. Lylyk P,
   4. Szikora I, et al

   . The Pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011;32:34–40 doi:10.3174/ajnr.A2421 pmid:21148256

   Abstract/FREE Full Text
10. 10.↵
    2. Szikora I,
    3. Berentei Z,
    4. Kulcsar Z, et al

    . Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the Pipeline embolization device. AJNR Am J Neuroradiol 2010;31:1139–47 doi:10.3174/ajnr.A2023 pmid:20150304

    Abstract/FREE Full Text
11. 11.↵
    2. Wakhloo AK,
    3. Lylyk P,
    4. de Vries J, et al

    . Surpass flow diverter in the treatment of intracranial aneurysms: a prospective multicenter study. AJNR Am J Neuroradiol 2015;36:98–107 doi:10.3174/ajnr.A4078 pmid:25125666

    Abstract/FREE Full Text
12. 12.↵
    2. Moon K,
    3. Albuquerque FC,
    4. Ducruet AF, et al

    . Treatment of ophthalmic segment carotid aneurysms using the Pipeline embolization device: clinical and angiographic follow-up. Neurol Res 2014;36:344–50 doi:10.1179/1743132814Y.0000000322 pmid:24617935

    CrossRefPubMed
13. 13.↵
    2. Zanaty M,
    3. Chalouhi N,
    4. Barros G, et al

    . Flow-diversion for ophthalmic segment aneurysms. Neurosurgery 2015;76:286–89 doi:10.1227/NEU.0000000000000607 pmid:25584955

    CrossRefPubMed
14. 14.↵
    2. Burrows AM,
    3. Cloft H,
    4. Kallmes DF, et al

    . Periprocedural and mid-term technical and clinical events after flow diversion for intracranial aneurysms. J Neurointerv Surg 2015;7:646–51 doi:10.1136/neurintsurg-2014-011184 pmid:25082803

    Abstract/FREE Full Text
15. 15.↵
    2. Sahlein DH,
    3. Fouladvand M,
    4. Becske T, et al

    . Neuroophthalmological outcomes associated with use of the Pipeline embolization device: analysis of the PUFS trial results. J Neurosurg 2015;123:897–905 doi:10.3171/2014.12.JNS141777 pmid:26162031

    CrossRefPubMed
16. 16.↵
    2. Kallmes DF,
    3. Hanel R,
    4. Lopes D, et al

    . International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

    Abstract/FREE Full Text
17. 17.↵
    2. Chalouhi N,
    3. Daou B,
    4. Kung D, et al

    . Fate of the ophthalmic artery after treatment with the Pipeline embolization device. Neurosurgery 2015;77:581–84; discussion 584 doi:10.1227/NEU.0000000000000887 pmid:26191974

    CrossRefPubMed
18. 18.↵
    2. Puffer RC,
    3. Kallmes DF,
    4. Cloft HJ, et al

    . Patency of the ophthalmic artery after flow diversion treatment of paraclinoid aneurysms. J Neurosurg 2012;116:892–96 doi:10.3171/2011.11.JNS111612 pmid:22224787

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Mattingly T,
    3. Kole MK,
    4. Nicolle D, et al

    . Visual outcomes for surgical treatment of large and giant carotid ophthalmic segment aneurysms: a case series utilizing retrograde suction decompression (the “Dallas technique”). J Neurosurg 2013;118:937–46 doi:10.3171/2013.2.JNS12735 pmid:23521551

    CrossRefPubMed
20. 20.↵
    2. Lai LT,
    3. Morgan MK

    . Outcomes for unruptured ophthalmic segment aneurysm surgery. J Clin Neurosci 2013;20:1127–33 doi:10.1016/j.jocn.2012.12.004 pmid:23746571

    CrossRefPubMed
21. 21.↵
    2. Yadla S,
    3. Campbell PG,
    4. Grobelny B, et al

    . Open and endovascular treatment of unruptured carotid-ophthalmic aneurysms: clinical and radiographic outcomes. Neurosurgery 2011;68:1434–43; discussion 1443 doi:10.1227/NEU.obo13e31820b4f85 pmid:21273934

    CrossRefPubMedWeb of Science